The mission of NOAP is to promote public safety through participation of potentially impaired healthcare professionals in monitored rehabilitation and recovery as an alternative to license discipline, emphasizing fitness to practice and retention of competent professionals. NOAP is committed to working in cooperation with regulatory and professional organizations toward this objective.

NOAP 2020 Annual Conference
March 16 - 19, 2020
Albuquerque Marriott Hotel, New Mexic

Healthcare Professionals - Mind, Body and Spirit: Effective Solutions for Treatment, Recovery, and Monitoring

Daily Schedule

Titles, Topics and Presenters all subject to change

Time Monday, March 16
11:30am - 4pm Registration
12noon - 2pm
CE: 2.00
Session 1. FSPHP Guidelines for 2020
  • Paul H. Earley, MD, DFASAM
2pm - 2:15pm Workshop Break  
2:15pm - 3:30pm
CE: 1.75
Session 2. Program Sharing
  • Kathie Simpson, RN, BSN, CACPN; NOAP President; Irwin, Pennsylvania
4pm - 4:45pm Exhibitor Welcome Networking  
  Dinner on your Own  
7:15pm - 8:15pm Support Group Meeting - Open  
Time Tuesday, March 17
7:30am - 8:30am Support Group Meeting  
8am - 4:30pm Registration  
8am - 9am Continental Breakfast with Exhibitors  
9am - 9:15am Opening Remarks/Announcements
  • Kathie Simpson, RN, BSN, CACPN; NOAP President; Irwin, Pennsylvania
9:15am - 10:30am
CE: 1.25
Session 3. Wholehearted Journey to Ethics for Healthcare Professionals
  • Maeve O'Neill, MEd, LCDC, LPC-S, CHC, CDWF/CDTLF; Chief Ethics and Compliance Officer, Addiction Campuses; Dallas, Texas
10:30am - 10:45am Break  
10:45am - 12:15pm
CE: 1.50
Session 4. Medication Assisted Treatment for Opioid Addiction Among Safety-Sensitive Workers: What Lurks Beneath the Controversy?  
  • Chris Bundy, MD, MPH; Executive Medical Director, Washington Physicians Health Program; Seattle, Washington


  1. State the risks, benefits and alternatives of opioid agonist treatment among safety-sensitive workers.
  2. Analyze opioid agonist treatment for safety-sensitive workers from the perspectives of individualized treatment vs. population management.
  3. Discuss how the opioid agonist controversy may be influenced by underlying attitudes and beliefs about the goals of health monitoring.
12:15pm - 1:15pm Business Meeting Lunch (open to all attendees and exhibitors)  
1:15pm - 2:15pm
CE: 1.00
Session 5. National Practitioner Data Bank Medicare and Medicaid Exclusion List (Video Conference)
  • Anastasia Timothy, MD, MPH; National Practitioner Data Bank; Washington, DC
  • Paul Lotterer, JD; National Practitioner Data Bank; Washington, DC


  1. Understand the laws, regulations, and main components of the NPDB.
  2. Define NPDB querying and reporting requirements and apply these requirements to a variety of scenarios.
  3. Learn how to self-query.
  4. Learn how to enter a narrative in a report.
    2:15pm - 2:45pm Break  
    2:45pm - 3:45pm
    CE: 1.00
    Session 6. Study Results and Implications: Outcomes of Substance Use Disorder Monitoring Programs
    • Kathleen Russell, JD, MN, RN; National Council of State Boards of Nursing (NCSBN); Chicago, Illinois
    • Richard A. Smiley MS, MA;  National Council of State Boards of Nursing (NCSBN); Chicago, Illinois
    3:45pm - 4:45pm
    CE: 1.00

    Session 7. Gambling Disorder: The Hidden Addiction

    • Jeffrey P. Wasserman, JD, CPRS, ICGC-I; Judicial Outreach and Development Director, Delaware Council on Gambling Problems, Inc.; Wilmington, Delaware


    1. Recognize the screening and diagnostic criteria for gambling disorder and who is at risk.
    2. Understand the connection between gambling disorder and substance use disorders.
    3. Appreciate the harms unique to gambling disorder through the speaker’s lived experience.
    4. Identify best practices for prevention and treatment of gambling disorder.
      Dinner on your Own  
    Time Wednesday, March 18
    8am - 4:45pm Registration  
    8am - 9am Full Breakfast with Exhibitors  
    9am - 10:15am
    CE: 1.25
    Session 8. LGBT: Substance Use Disorder and Treatment
    • Melissa Lee Warner, MD
    10:15am - 10:30am Break  
    10:30am - 12noon
    CE: 1.50

    Session 9. MRO / Toxicology Panel Discussion

    • Moderator: Kathie Simpson, RN, BSN, CACPN
    • James Ferguson, DO, DFASAM, C-MRO; FSSolutions; Chalfont, Pennsylvania
    • Joe Jones, PhD, USDTL; Des Plaines, Illinois
    • Barry Lubin, MD, FASAM, MRO; Affinity Online Solutions; Vienna, Virginia
    • Donna Smith, PhD, EdD; RecoveryTrek; Virginia Beach, Virginia
    • Anthony Costantino, PhD, F-ABFT; DrugScan, Inc.


    1. Discuss the pros and cons of PEth vs blood spot.
    2. Describe the limitations of hair testing and understand how that impacts the interpretation of their program results.
    3. Describe the anatomy of a fingernail and how drug is incorporated into fingernail.
    4. Relate case study reports from the literature and our laboratory experience to better interpret their cases at their program.
    1:45pm - 5pm Meet in Hotel Lobby for Group Event - Sandia Peak Tram
    Separate registration fee required. See
      Dinner on your Own  
    Time Thursday, March 19
    7am - 8am Support Group Meeting  
    8am - 9am Continental Breakfast with Exhibitors  
    9am - 10:30am
    CE: 1.50
    Session 10. Walking the Edge: Passion and Pathology in Recovery
    • Sherry Young, PhD, CSAT; RightFit Consulting


    1. Identify "the edge," those precarious points where passion and pathology walk a fine line in recovery, service, and self-care.
    2. Name ways to cultivate care, containment, and spiritual resourcing.
    10:30am - 10:45am Break  
    10:45am - 12:15pm
    CE: 1.50

    Session 11. Evaluating and Addressing Depression and Suicide in the Medical/Licensed Professional

    • Lantie Jorandby, MD; Chief Medical Officer, Lakeview Health; Jacksonville, Florida
    12:15pm - 1:30pm Membership Luncheon (open to all attendees and exhibitors)  
    1:30pm - 2:45pm
    CE: 1.25
    Session 12. Mindfulness and Spiritual Awakening
    • Wolf Yoxall
      Conference Closing  




    Powered by Wild Apricot Membership Software